None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Adult male aged 19 to 55 years at screening 2) A body mss index between 19 and 27 kg/m2 at screening 3) A subject who is able to understand the study, and to provide written informed consent voluntarily after being fully informed of the study objectives, procedures and study drug 4) A subejct who is able to participate the whole study period
Exclusion criteria
Exclusion criteria: 1) A subject who has the medical history of or has the clinically significant hepatobiliary, renal, gastrointestinal, respiratory, musculoskeletal, endocrinal, hemato-oncologic, or cardiovascular disease 2) A subject who has systolic blood pressure 1.5 times of upper normal limit 11) A subject who has the glomerular filtration rate (GFR) calculated by plasma creatinine values < lower normal limit 12) A subject who is inadequate for the clinical trial by the investigator’s decision
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cmax, AUClast of valproic acid | — |
Secondary
| Measure | Time frame |
|---|---|
| tmax, t1/2, AUCinf of valproic acid | — |
Countries
Korea, Republic of
Contacts
Samsung Medical Center